Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

End-of-day quote. End-of-day quote  - 08/26
57.05 EUR   +0.62%
08/26 DIASORIN : Reagents, controls and consumables for automatic immunoas..
08/10 DIASORIN : acquisition of DiaSorin and Alere brand materials
08/09 Kyowa Hakko Kirin Announced Kyowa Medex Acquired approval for Ins..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
08/22/2016 08/23/2016 08/24/2016 08/25/2016 08/26/2016 Date
56.75(c) 57.55(c) 57.55(c) 56.7(c) 57.05 Last
117 677 92 163 57 849 44 573 23 183 Volume
0.00% +1.41% 0.00% -1.48% +0.62% Change
More quotes
Financials (€)
Sales 2016 573 M
EBIT 2016 176 M
Net income 2016 115 M
Finance 2016 73,4 M
Yield 2016 1,27%
Sales 2017 640 M
EBIT 2017 199 M
Net income 2017 130 M
Finance 2017 90,7 M
Yield 2017 1,40%
P/E ratio 2016 27,44
P/E ratio 2017 24,30
EV / Sales2016 5,44x
EV / Sales2017 4,85x
Capitalization 3 192 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.Its business segments are the geographic locations in which it operates: Italy and the United Kingdom; Europe which comprises Germany, France, Belgium, the Netherlands, Spain, Portugal,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
08/26 DIASORIN : Reagents, controls and consumables for automatic immunoassay analyzer..
08/18 DIASORIN : Webinar Details Parathyroid Hormone Testing in Chronic Kidney Disease..
08/10 DIASORIN : acquisition of DiaSorin and Alere brand materials
08/09 Kyowa Hakko Kirin Announced Kyowa Medex Acquired approval for Insurance Cover..
07/28 DIASORIN : starts selling Vitamin D in Japan
07/27 DIASORIN : Reagents, controls and consumables for automatic immunoassay analyzer..
07/21DJQUEST DIAGNOSTICS : Profit Rises, Helped by Lower Costs
06/29 DIASORIN : Webinar Spotlights Evolution of PTH and Vitamin D Testing
06/28 DIASORIN : Webinar Spotlights Evolution of PTH and Vitamin D Testing
06/06DJQUEST DIAGNOSTICS : to Move Headquarters to Secaucus
More news
Sector news : Diagnostic & Testing Substances
08/27 ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
08/26DJST JUDE MEDICAL : . Jude Denies Report Its Heart Devices Are Vulnerable to Cyber..
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
08/26DJST JUDE MEDICAL : . Jude Denies Report Its Heart Devices Are Vulnerable to Cyber..
08/26 MUDDY WATERS SAYS ST. JUDE SHARES CO : Cnbc
More sector news : Diagnostic & Testing Substances
News from SeekingAlpha
03/30 DiaSorin buys Quest's diagnostic products business for $300M
Advertisement
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 56,2 €
Spread / Average Target -1,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Francesco Colotta Chief Medical Officer & Senior Corporate VP
Chen Menachem Even Executive Director & SVP-Commercial Operations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA17.03%3 573
BIOMERIEUX14.24%5 545
SICHUAN MAKER BIOTECHN..--.--%2 132
NINGBO MEDICALSYSTEM B..--.--%1 802
SHANGHAI KEHUA BIO-ENG..--.--%1 769
GUANGZHOU WONDFO BIOTE..--.--%1 410
More Results